Immunopathogenesis of rheumatic diseases in the context of neuroendocrine interactions

Annals of the New York Academy of Sciences

Volumn 966, Issue , 2002, Pages 355-364

  Wahle, M ^a   Krause, A ^b   Pierer, M ^a   Hantzschel H ^a   Baerwald, C G O ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Immunopathogenesis; Neuroendocrine interactions; Rheumatic diseases

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR;

AUTONOMIC NERVOUS SYSTEM; CONFERENCE PAPER; DNA POLYMORPHISM; ETHNIC DIFFERENCE; EVIDENCE BASED MEDICINE; GENETIC SUSCEPTIBILITY; HORMONE SENSITIVITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOPATHOGENESIS; LYMPHOID CELL; MARKER GENE; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; NONHUMAN; PROTEIN EXPRESSION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STRESS;

EID: 0036300885     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04235.x     Document Type: Conference Paper

References (65)

1. Psychoneuroimmunology: Interactions between the nervous system and the immune system
2. Noradrenergic and peptidergic innervation of secondary lymphoid organs: Role in experimental rheumatoid arthritis
3. Noradrenergic sympathetic neural interactions with the immune system: Structure and function
4. Catecholamine influences and sympathetic neural modulation of immune responsiveness
5. In vitro desensitization of beta adrenergic receptors in human neutrophils: Attenuation by corticosteroids
6. Expression and in-vivo modulation of alpha- and beta-adrenoceptors on human natural killer (CD16+) cells
7. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release
8. Beta-adrenergic receptors are different in subpopulations of human circulating lymphocytes
9. Changes in beta-adrenergic receptor distribution on immunocytes during differentiation: An analysis of T cells and macrophages
10. Continuous in vivo treatment with catecholamines suppresses in vitro reactivity of rat peripheral blood T-lymphocytes via alpha-mediated mechanisms
11. Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis
12. Disease activity related catecholamine response of lymphocytes from patients with rheumatoid arthritis
13. Reciprocal interactions between the neuroendocrine and immune systems during inflammation
14. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
15. Desmopressin and low-dose ACTH test in rheumatoid arthritis
16. Circadian variation in disease activity in rheumatoid arthritis
17. Adrenal secretion of cortisol in patients with rheumatoid arthritis
18. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats
19. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
20. Human corticotropin releasing hormone gene is located on the long arm of chromosome 8
21. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis
22. Desmopressin, ovine CRH, and low-dose ACTH tests: Tools for the study of the hypothalamic-pituitary-adrenal axis in pre-menopausal rheumatoid arthritis patients
23. A new XmnI polymorphism in the regulatory region of the corticotropin releasing hormone gene
24. Corticotropin releasing hormone promoter region polymorphisms in rheumatoid arthritis
25. Distribution of corticotropin-releasing hormone promoter polymorphism in different ethnic groups: Evidence for natural selection in human populations
26. Corticotropin releasing hormone (CRH) promoter polymorphisms in various ethnic groups of patients with rheumatoid arthritis
27. Multipoint linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region
28. Diminished autonomic nervous system responsiveness in rheumatoid arthritis of recent onset
29. Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus
30. Autonomic nervous dysfunction in Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA): Possible pathogenic role of autoantibodies to autonomic nervous structures
31. Beta-adrenergic agonists suppress Chronic/Relapsing Experimental Allergic Encephalomyelitis (CREAE) in Lewis rats
32. Beta 2-adrenergic mechanisms in experimental arthritis
33. Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis
34. Propranolol and the treatment of rheumatoid arthritis
35. Cyclic nucleotides in joint fluid in rheumatoid arthritis and in Reiter's syndrome
36. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: Mechanisms of action
37. Catecholamine action and immunologic reactivity
38. Functional alpha1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis
39. Neuroendocrine mediators up-regulate alpha1b- and alpha1d-adrenergic receptor subtypes in human monocytes
40. Beta-adrenergic receptors and their regulation
41. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB
42. Transcriptional regulation by cyclic AMP
43. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response
44. Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis
45. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis
46. Beta 2-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatic diseases
47. Correlation between density of beta 2-adrenergic receptors on peripheral blood mononuclear cells and serum levels of soluble interleukin-2 receptors in patients with chronic inflammatory diseases
48. Influence of cytokines on the density of beta 2-adrenergic receptors on peripheral blood mononuclear cells in vitro
49. Alterations in beta-adrenoceptor density on T-lymphocytes upon activation with interleukin-2 and phytohaemagglutinin
50. Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells
51. Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases
52. Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors
53. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages
54. Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis
55. Regulation of beta2-adrenergic receptors on CD4 and CD8 positive lymphocytes by cytokines in vitro
56. Catecholamines increase lymphocyte beta 2-adrenergic receptors via a beta 2-adrenergic, spleen-dependent process
57. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes
58. Association of in vitro immune functions with the severity of the disease in rheumatoid arthritis
59. The role of adrenoceptor-mediated signals in the modulation of lymphocyte function
60. Reduced catecholamine response of lymphocytes from patients with rheumatoid arthritis
61. Chronic terbutaline treatment desensitizes beta-adrenergic inhibition of lymphocyte activation in healthy volunteers
62. cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization
63. Dialogue between the brain and the immune system in juvenile chronic arthritis
64. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help
65. Intracellular cAMP and beta 2-adrenergic receptors on CD19+ lymphocytes in patients with rheumatoid arthritis